Plain-English translation of NCT06067139 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Diabetes Mellitus, Type 2 research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether a digital cognitive behavioral therapy for insomnia (CBT-I) program—a proven method to improve sleep through habit changes and addressing unhelpful beliefs about sleep—can help lower blood sugar levels and reduce diabetes risk in people with prediabetes. Researchers know that poor sleep is linked to higher diabetes risk, so they want to see if treating sleep problems can actually prevent diabetes from developing.
Type 2 diabetes is a serious health crisis affecting millions of Americans, but new research shows that insomnia is a major, treatable risk factor for developing diabetes. This trial exists to test whether improving sleep through this treatment could be an effective way to prevent people with prediabetes from progressing to full diabetes.
You likely qualify if…
You likely don't qualify if…
You will be randomly assigned to one of two groups: either a 6-week digital sleep improvement program (an interactive web app you access on any device), or an educational website with general sleep information. Over 33 weeks total, you'll complete three assessment visits where researchers measure your blood sugar, sleep quality, diet, exercise, and mood. The program is designed to fit into your life at home, without requiring in-person visits for the main treatment.
AI-generated summary from trial data · Jul 4, 2026 · Not medical advice
United States